Z-2152-2025 Class II Ongoing

Recalled by Beckman Coulter Inc. — Brea, CA

FDA device recall Z-2152-2025 was initiated by Beckman Coulter Inc. on Jun 12, 2025 and is designated Class II. Reason for recall: A specific lot of bovine serum albumin (BSA) used for manufacturing of coated tubes (CT) that are included in the Estrone RIA kit lots caused different affinity of manufactured coated tubes to patient… The recall status is ongoing. Affected quantity: 496 units.

Recall details

Product Type
Devices
Report Date
Jul 30, 2025
Initiation Date
Jun 12, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
496 units

Product description

Estrone RIA, REF: DSL8700. Estrone RIA is an IVD used for the quantitative measurement of estrone in human serum and plasma.

Reason for recall

A specific lot of bovine serum albumin (BSA) used for manufacturing of coated tubes (CT) that are included in the Estrone RIA kit lots caused different affinity of manufactured coated tubes to patient samples, causing falsely increased assay results for the impacted Estrone RIA kits.

Distribution pattern

US: North Carolina OUS: Argentina, Austria, Belgium, Canada, France, Germany, Greece, Hungary, Italy, Netherlands

Code information

UDI: 15099590211615/Lot: 250106D, 250203C, 250203D, 250303C, 250331C, 250428C, 250526C

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2152-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2152-2025. Report a data issue: hello@regdatalab.com.